Cargando…
In vitro effects of gamma-secretase inhibition in HPV-positive and HPV-negative head and neck squamous cell carcinoma
BACKGROUND: New chemotherapy agents are warranted for head and neck squamous cell carcinoma (HNSCC), particularly for incidence-rising HPV-positive tumors. Based on the evidence of Notch pathway involvement in cancer promotion and progression, we aimed to gain insights into the in vitro antineoplast...
Autores principales: | Varatanovic, Sara, Maier, Tobias, Al-Gboore, Sega, Stoiber, Stefan, Kandathil, Sam Augustine, Quint, Clemens, Brennus, Charlotte, Heiduschka, Gregor, Kadletz-Wanke, Lorenz, Brkic, Faris F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140088/ https://www.ncbi.nlm.nih.gov/pubmed/36809443 http://dx.doi.org/10.1007/s10637-023-01334-x |
Ejemplares similares
-
High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients
por: Scheiflinger, Alexandra, et al.
Publicado: (2023) -
In vitro antineoplastic effects of MK0752 in HPV-positive head and neck squamous cell carcinoma
por: Varatanovic, Sara, et al.
Publicado: (2023) -
Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma
por: Brkic, Faris F., et al.
Publicado: (2022) -
Evaluation of the Prognostic Capacity of a Novel Survival Marker in Patients with Sinonasal Squamous Cell Carcinoma
por: Brkic, Faris F., et al.
Publicado: (2022) -
β-CATENIN is a positive prognostic marker for HPV-positive head and neck squamous cell carcinoma
por: Stoiber, Stefan, et al.
Publicado: (2023)